Table 3. Correlation between the Bb/pAb and mAb assays by markers and characteristics of the women in the serum subset (n=214).
|
Mesothelin bead-based assays |
HE4 bead-based assays |
|||
---|---|---|---|---|---|
Characteristics | n | r | p-value | r | p-value |
All Cases and Controls | 214 | 0.8993 | <0.001 | 0.8920 | <0.001 |
Cases Only | 71 | 0.9192 | <0.001 | 0.9504 | <0.001 |
Early Stage (stage I) | 23 | 0.9147 | <0.001 | 0.7885 | <0.001 |
Stages II-IV |
48 |
0.8955 |
<0.001 |
0.9493 |
<0.001 |
Healthy Controls | 58 | 0.7440 | <0.001 | 0.1508 | 0.2629 |
Benign Controls | 53 | 0.7225 | <0.001 | 0.4161 | 0.002 |
Surgical Controls |
32 |
0.7943 |
<0.001 |
0.5293 |
0.002 |
Serous | 44 | 0.8945 | <0.001 | 0.9536 | <0.001 |
Mucinous | 6 | 0.8237 | 0.044 | 0.4914 | 0.3222 |
Endometrioid | 6 | 0.8634 | 0.027 | 0.9905 | <0.001 |
Clear Cell | 5 | 0.9367 | 0.019 | 0.7118 | 0.178 |
Other Histologies | 10 | 0.9078 | <0.001 | 0.9548 | <0.001 |